Download - SPONSORSHIP OPPORTUNITIES - California Life Sciences ... · SPONSORSHIP OPPORTUNITIES Platinum Sponsor Benefits - $10,000 • Recognition of research milestone, product development

CHI-CALIFORNIA HEALTHCARE INSTITUTESPONSORSHIP OPPORTUNITIES

Molly Ingraham, Vice President Business [email protected] or (858) 456-8884www.chi.org/sponsorships

1

ADVANCINGCALIFORNIA

BIOMEDICAL RESEARCH AND INNOVATION

*BRAND RECOGNITION * MARKETING OPPORTUNITIES * NETWORKING * ACCESS*

SPONSORSHIPOPPORTUNITIES



1

Dear colleagues and friends,

On behalf of CHI and our board of directors, I want to thank you for supporting the activities of CHI. CHI’s more than 275 life sciences companies and academic institutions deliver a powerful message about the number of people who work in the biomedical field, our economic impact on the state, and our global leadership in translating basic science into products that save and improve patients’ lives. In 2013, CHI will embark on its 20th year of advancing biomedical research, investment and innovation through effective advocacy of policies to improve public health and drive California life sciences sector.

CHI is well positioned to continue driving the innovation agenda in Sacramento and Washington. In this critical time for the California life sciences industry, we appreciate and rely on your continued financial support and active participation in our organization and events. At our events we strive to deliver high value content and timely analysis of trends affecting our industry to meet the immediate demands of your organizations.

Thank you for your continued support of CHI, the voice of the California biomedical community in Sacramento and on Capitol Hill. I look forward to working with you.

Sincerely,

David L. Gollaher, Ph.D.President & CEOCHI-California Healthcare Institute

LETTER FROM THE CEODAVID L. GOLLAHER, PH.D.



2

TABLE OF CONTENTS

AUDIENCE DEMOGRAPHICSPROGRAM DESCRIPTIONSSPECIAL PROJECTSCONTRIBUTING TO CHIPAC CHI SCHOLARSHIP PROGRAMS CHI DIAMOND SPONSORSHIP PROGRAMSPONSORSHIP LEVELS AT A GLANCECHI BOARD OF DIRECTORSCHI MEMBERS SPONSORSHIP COMMITMENT FORM

34

1112131314161719

ABOUT CHI

CHI is the only statewide organization in California and represents more than 275

leading biotechnology, medical device, diagnostics, and pharmaceutical companies,

public and private academic research organizations, along with the legal,

accounting, consulting and financial service organizations that support them. CHI’s

mission is to advance responsible public policies that foster medical innovation and

promote scientific discovery. CHI’s website is www.chi.org. Follow us on Twitter

@calhealthcare and on Facebook.

Our Value and Mission:

The mission of CHI is to research, develop, and advocate policies and actions that

promote biomedical science, biotechnology, pharmaceutical and medical device

innovation in California.

• Create a favorable environment for the state’s biomedical and healthcare technology community to

discover, produce, and deliver products that benefit society.

• Provide a forum to identify, analyze, and develop positions on public policy issues that affect

California’s biomedical and healthcare technology interests.

• Conduct research as a basis for advocating responsible state and federal policies.

• Communicate to public officials, providers, patients, and the general public the value of the state’s

healthcare technology community for the health and economic well-being of our nation’s citizens

and the economic growth of California.

• Identify and communicate the value of innovation with regard to cost, benefit, and patients’ quality

of life.



3

AUDIENCE DEMOGRAPHICS



4

PROGRAM DESCRIPTIONS

WINTER - ANNUAL CALIFORNIA BIOMEDICAL INDUSTRY REPORT

The Annual California Biomedical Industry Report illustrates the important roles biomedical research, development, and manufacturing play in California’s economy and ultimately in the nation’s health. The report provides an overview of employment trends, wages, the product development pipeline, and opportunities and risks for the industry in California, home to the largest concentration of biomedical companies in the world. CHI, in partnership with BayBio and PwC, publishes the report annually in print and on an interactive website that is regularly updated with industry data, news and accomplishments. The report is launched through a series of events to publicize its key findings to the media, policy makers and the California life sciences community including: a press conference with an invitation-only networking breakfast held in San Francisco during the Annual J.P. Morgan Healthcare Conference, a reception with state elected and appointed officials in Sacramento, and regional program panel discussions held in key biomedical clusters throughout the State.

SPONSORSHIP OPPORTUNITIES

Platinum Sponsor Benefits - $10,000 • Recognition of research milestone, product development

achievement, patient care advance, or other significant company accomplishment on interactive website for the Annual California Biomedical Industry Report*

• Opportunity to participate as media spokesperson for launch of Annual California Biomedical Industry Report

• Opportunity to participate in speaking or other role at regional launch events for Annual California Biomedical Industry Report*

• Platinum-level preferred seating at press conference with an invitation-only networking breakfast to be held in San Francisco during the Annual J.P. Morgan Healthcare Conference in January

• Table for eight guests at press briefing and event to be held in San Francisco during the Annual J.P. Morgan Healthcare Conference in January.

• Photo opportunity with policymakers at launch event in Sacramento• Invitation to exclusive sponsor-only reception with policymakers in

Sacramento• Platinum-level recognition on printed and electronic materials• Platinum-level corporate logo positioning on event signage• Platinum-level recognition on CHI, BayBio and partnering

organization websites• Platinum-level recognition during event presentations

Company recognition in CHI printed material is subject to deadlines determined by CHI.*Subject to CHI, PwC, and BayBio approval

Non-Profit/Academic Research Institution Sponsor - $3,500

• Non-Profit/Academic Research Institution-level recognition on printed and electronic materials

• Non-Profit/Academic Research Institution-level corporate logo positioning on event signage

• Non-Profit/Academic Research Institution-level recognition on CHI website

• Non-Profit/Academic Research Institution-level recognition during dinner presentation

• Non-Profit/Academic Research Institution-level preferred seating at dinner

Gold Sponsor Benefits - $5,000 • Two complimentary tickets to press

conference with an invitation-only networking breakfast to be held in San Francisco, California during the Annual J.P. Morgan Healthcare Conference in January

• Photo opportunity with policymakers at launch event in Sacramento

• Invitation to exclusive sponsor-only reception with policymakers in Sacramento

• Gold-level recognition on printed and electronic materials

• Gold-level corporate logo positioning on event signage

• Gold-level recognition on CHI, BayBio and partnering organization websites

• Gold-level recognition during event presentations



5

SPRING - ANNUAL RECEPTION ON CAPITOL HILL (WASHINGTON, D.C.)

CHI gathers legislators, their staff and leaders from the lifesciences and academic communities in California for a celebration of California biomedical innovation at our nation’s capital. Hundreds of attendees enjoy conversation with public policymakers and California’s biotech opinion leaders about the issues that matter most to our industry. At the invitation-only dinner following the reception, we honor legislators who have supported the advancement of biomedical innovation in California. Past awardees have included Fred Upton, Chairman, House Energy & Commerce Committee, Representative Kevin McCarthy, Representative Anna Eshoo, Senator Dianne Feinstein and Representative Mike Thompson.


Platinum Sponsor Benefits - $7,500

• One seat at honoree table with member of Congress* at private, invitation-only Board of Directors dinner

• Table for eight guests at the private, invitation-only Board of Directors dinner• Photo opportunity and special memento framed photograph with member of Congress*• Opportunity for participation in dinner presentation with member of Congress*• Platinum-level recognition on commemorative dinner program• Platinum-level recognition on printed materials promoting the reception to legislators,

legislative staff, life sciences industry executives, patient advocates and health policy community

• Platinum-level recognition on broadcast emails to key audiences listed above• Platinum-level recognition on CHI website • Platinum-level recognition during the dinner

*schedule permitting

Company recognition in CHI printed material is subject to deadlines determined by CHI.

Gold Sponsor Benefits - $3,000

• Two complimentary tickets to private, invitation-only dinner honoring member of Congress

• Gold-level recognition on printed materials promoting the event to legislators, legislative staff, life sciences, industry executives, patient advocates and health policy community

• Gold-level recognition on broadcast emails to key audiences listed above

• Gold-level recognition on CHI website



6

Silver Sponsor Benefits - $5,000

• Two complimentary admissions to event• Opportunity to display corporate literature and exhibit

at event • Silver-level recognition during program proceedings• Silver-level placement of corporate logo and branding in

printed and electronic materials promoting the event• Silver-level recognition on CHI website and partner

organization websites• Silver-level recognition on event signage

SUMMER - AN EVENING WITH THOUGHT LEADERS (SOUTHERN CALIFORNIA)

CHI’s annual summer program “An Evening with Thought Leaders” brings together hundreds of leaders from California’s biomedical industry, academic research community, entrepreneurs, investors, healthcare providers, policy experts and patient advocates. Past speakers have included: • Dr. Charles Edwards, former director of the U.S. Food and Drug Administration, past president and CEO of Scripps

Clinic and Research Foundation, and former president and CEO of Scripps Institutes of Medicine and Science• Brook Byers, well-known venture capitalist• Dr. Richard Murphy of the California Institute for Regenerative Medicine and Salk Institute• Former Secretary of State and Distinguished Fellow at the Hoover Institution, Stanford University, George P. Shultz• Dr. Eric Topol of the West Wireless Health Institute• Margaret Anderson, Executive Director, FasterCures • Dr. Robert Figlin, Director Division of Hematology/Oncology, Cedars Sinai • Dana Goldman, Ph.D., Director, USC Leonard D. Schaeffer Center for Health

Policy and Economics• Frank McCormick, Ph.D., Director of the Helen Diller Family Comprehensive

Cancer Center at UCSF, President of the American Association of Cancer Research

• Kim Popovits, President & CEO, Genomic Health



• Exclusive sponsorship – one sponsorship per service sector• Eight complimentary admissions to program • Table of eight at dinner • Opportunity to speak at event*• Distribution of giveaway to attendees*• Opportunity to serve on Event Steering Committee* • Opportunity to display corporate literature and exhibit at event • Platinum-level preferred seating at event• Platinum-level recognition during program proceedings• Platinum-level placement of corporate logo and branding in printed and

electronic materials promoting the event• Platinum-level recognition on CHI website and partner organization

websites• Platinum-level recognition on event signage

*Subject to CHI approvalCompany recognition in CHI printed material is subject to deadlines determined by CHI.

Gold Sponsorship Opportunity - $10,000

• Opportunity to serve on Event Steering Committee*

• Four complimentary admissions to event

• Opportunity to display corporate literature and exhibit at event

• Gold-level recognition during program proceedings

• Gold-level placement of corporate logo and branding in printed and electronic materials promoting the event

• Gold-level recognition on CHI website and partner organization websites

• Gold-level recognition on event signage



7

FALL - DIAGNOSTICS FORUM

The diagnostics industry is changing rapidly, fueled by basic scientific advances in genomics and molecular genetics, along with technological innovations in areas like gene sequencing. It is clear that policy, reimbursement and regulation have not kept pace with this fast-moving field. To build a better understanding of the complex regulatory and political environment surrounding diagnostics, and to refine our advocacy agenda, CHI hosts this half-day forum. CHI convenes industry executives, policymakers and regulators, as well as policy experts to discuss topics such as regulation of laboratory-developed tests, regulatory approaches to sequencing, reimbursement of advanced diagnostics, reimbursement, and other vital topics.

SPONSORSHIP OPPORTUNITY

CHI DIAGNOSTICS WORKING GROUP

23andMeAbbott Laboratories

BDCardioDx

CeleraCepheid

Crescendo BioscienceGenentech

Genomic HealthHologic + Gen-Probe

GenzymeIllumina

Johnson & JohnsonKleiner Perkins Caufield & Byers

NovartisPfizer

Roche DiagnosticsWave 80 Biosciences

Sponsor Benefits - $3,500

• Opportunity to present at forum• Opportunity to guide white paper development and distribution

strategy• Two complimentary passes to forum• Recognition on printed and electronic materials promoting the

forum• Recognition on CHI website• Recognition during the forum program and reception




8

FALL - CHI ANNUAL MEETING (BAY AREA)

CHI’s Annual Meeting is focused on the relationship between biomedical innovation and public policy. This event brings together delegates from more than 200 of CHI’s member organizations with policymakers to discuss critical issues and opportunities facing the biomedical community. The goal of the forum is to produce a clearer understanding of the biomedical community’s work and needs, and how the industry can sustain California’s leadership in medical innovation.


Exclusive — Board of Directors Dinner Sponsor Benefits - $25,000

• Six complimentary full access registrations• Table of eight at private, invitation-only Board of Directors dinner • Opportunity to display corporate literature at forum and at dinner• Leveraged exposure in promotional campaign that reaches more than 5,000

California biomedical industry executives• Opportunity for senior level management to introduce panel discussion at

forum• Opportunity for senior level management to address dinner guests• Recognition at event• Recognition in attendee materials• Recognition on CHI website• Recognition on printed and electronic materials promoting the event• Corporate logo on event signage

Gold Sponsor Benefits - $10,000

• Four complimentary full access registrations• Leveraged exposure in promotional campaign to reach more than 5,000

California biomedical industry executives.• Gold-level recognition in attendee materials• Gold-level recognition on CHI website • Gold-level recognition on printed and electronic materials promoting the

event• Opportunity to display corporate literature• Corporate logo on event signage


• Six complimentary full access registrations• Opportunity to display corporate literature• Leveraged exposure in promotional campaign to reach

more than 5,000 California biomedical industry executives• Opportunity for senior level management to introduce panel

discussion• Distribution of giveaway to attendees*• Recognition at event• Platinum-level recognition in attendee materials• Platinum-level recognition on CHI website• Platinum-level recognition on printed and electronic

materials promoting the event• Corporate logo on event signage

*subject to CHI approval




9


Silver Sponsor Benefits - $5,000

• Two complimentary full access registrations• Leveraged exposure in promotional campaign to reach more

than 5,000 California biomedical industry executives.• Silver-level recognition in attendee materials• Silver-level recognition on CHI website• Silver-level recognition on printed and electronic materials

promoting the event• Corporate logo on event signage

Coffee and Networking Break Sponsor Benefits - $5,000

• Two complimentary registrations• Opportunity to display corporate literature• Logo prominently displayed throughout the break area • Recognition on printed and electronic materials promoting the

event

Patient & Non-Profit Organization Scholarship Sponsor Benefits - $5,000

• Patient & Non-Profit Organization Scholarship-level recognition of sponsor to scholarship recipients

• Two complimentary full-access registrations• Opportunity to display corporate literature • Recognition on printed and electronic materials promoting the

event• Corporate logo on event signage• Opportunity to meet with speakers and other VIPs in a more

private setting

“Innovations like those being developed at NuVasive and at other companies throughout California are having a huge impact on the economy and on the improvement of human

lives. This event allows us to elevate the importance of keeping biomedical companies

and jobs in California.” - Keith C. Valentine, President and Chief

Operating Officer, NuVasive



10

ANNUAL END OF SESSION RECEPTION (WASHINGTON,D.C.)

To celebrate the end of the legislative session in Washington D.C., CHI brings together legislators, staff and biomedical industry leaders in an informal setting. The event attracts key members of Congress, top-level legislative staff and other government officials. During the event, attendees have the opportunity to meet and talk one-on-one with policymakers and their staff about the importance of biomedical innovation and scientific advancement in California and globally.

SPONSORSHIP OPPORTUNITY

Sponsor Benefits - $1,500

• Recognition on printed materials promoting the event to legislators, legislative staff, life sciences industry executives, patient advocates and health policy community

• Recognition on broadcast emails to key audiences listed above

• Corporate logo on CHI website• Recognition during the reception

CHI POLICY ROUNDTABLE SERIES

CHI hosts private, informal roundtable discussions with state and federal policymakers that offer important opportunities to engage in high level discussion. Topics include the importance of life sciences research, development and innovation in and around legislators’ districts, science funding, capital formation, FDA regulation, science and math education, and workforce development. These roundtables are small, open to only 15 CEOs at a time.

SPONSORSHIP OPPORTUNITYUnderwriting opportunities for CHI’s policy roundtable series are customized for each event.



11

NATIONAL INSTITUTES OF HEALTH: RETURN ON INVESTMENT CASE STUDIES

Sponsorships are available at the Corporate Level ($10,000) and Non-Profit/Academic Research Institution Level ($5,000).

NIH is the world’s leading sponsor of biomedical research. California’s preeminence in the life sciences industry derives, in large part, from universities and private research institutes supported by the NIH. During the past decade the NIH budget, after doubling from 1997-2002, has barely kept up with inflation. And the percentage of investigator-initiated grant proposals approved for funding has steadily declined. There now is a prospect for significant cuts in 2013, owing to sequestration and general pressure to reduce discretionary federal spending. While the immediate effects of NIH cuts would be felt by organizations engaged in basic research, the longer-term impact would hamper companies that provide research tools and, eventually, weigh on the whole biomedical sector as its main source of new inventions declined.

Several published economic studies produced data to demonstrate how the NIH drives job creation and economic growth. But CHI believes that, within the current political environment with its emphasis on job creation and U.S. competitiveness, there’s an urgent opportunity to illustrate the value of NIH funding, and the return on government investment in basic science, by developing a series of case studies. Our basic concept is to select areas – beginning with recombinant DNA and HIV/AIDS – in which comparatively modest funding from NIH served as catalysts for tremendous advances, subsequently encouraging private-sector investment and commercial activity, and rapidly bringing major advances in human health. CHI’s communication efforts will include a joint release to the media and general public of the reports with NIH, congressional briefings and one on one meetings with legislators and their staffs. Sponsors of the project will have the opportunity to participate in content development and communication and project launch activities.

COVERAGE, PAYMENT AND THE VALUE OF BIOMEDICAL INNOVATION

Sponsorships are available at the Presenting Level ($25,000) and Supporting Level ($10,000).

Reasonable coverage and payment policies – beginning with CMS, Medi-Cal and other public sector payers – are essential to sustaining U.S. medical innovation. As reimbursement has declined, in some cases the return on investment in R&D for new products has fallen below the cost of capital, making R&D value destroying.

In order to advocate for pro-innovation policies in an environment with tight fiscal constraints and high levels of political polarization, CHI is designing a comprehensive program to run through 2013 and beyond. We are presently engaged in discussion with Avelere Health, a Washington-based consulting firm that works with many CHI drug and device companies, about a partnership that would tap into the firm’s expertise in data analytics and government payers. As with our FDA project with Boston Consulting Group, we plan to organize a committee of CHI members to guide the work. Sponsors of the project will be invited to serve on the advisory committee.

Our approach will include: Developing a data-driven approach for estimating the value of state-of-the-art diagnostic tests and treatments; Navigating the changing currents of comparative effectiveness research, aiming to ensure that it is not used as a tool to limit access to advanced technologies; Keeping close watch on the Independent Payment Advisory Board (IPAB), a panel of 15 presidential appointees charged with making Medicare cuts to achieve budgetary goals; and Monitoring the progress of California’s health insurance exchanges and the development of essential benefits to ensure that efforts to reign in health insurance premiums, exchanges do not impose new barriers to innovative technologies.

SPECIAL PROJECTS



12

The California Healthcare Institute State Political Action Committee (CHIPAC) is a bipartisan state political action committee established to solicit voluntary political contributions. The CHIPAC enables companies and individuals to combine their resources to support state-level candidates who demonstrate a dedication to understanding California’s biomedical industry, encouraging the industry to flourish in the state,

and fostering drug, device and diagnostics innovation. Unlike federal law, corporations are allowed under California law to make political contributions to a state PAC. As of January 1, 2009, the limit is $6,500 per calendar year.

What is the purpose of the CHIPAC? The purpose of the CHIPAC is to elevate awareness of the biomedical industry’s goals through increased education and participation in the political process in California. The CHIPAC aims to educate, inform and elect candidates to state office who will support and promote California’s biomedical industry. The CHIPAC allows the biomedical industry to support candidates who share our values and want to help our industry conduct business in California; develop, commercialize and market new medical products; and maintain a highly skilled workforce.

Why contribute to the CHIPAC? The CHIPAC allows you and your company the opportunity to unite with other industry leaders to ensure that Sacramento policy makers hear your views. Elected officials in California have direct influence on how you and your company conduct business in the state and how your products are developed, regulated and marketed in California. By contributing to the CHIPAC, you can help ensure that these key officials understand and appreciate the unique challenges facing medical innovators.

Who may contribute to the CHIPAC? Any individual or company that has an interest in maintaining a business, legal and regulatory climate that supports and advances biomedical innovation in California may contribute to the CHIPAC.

How does the CHIPAC decide where to direct political contributions? All members of the CHIPAC are involved in decisions on directing political contributions to state-level candidates. In addition, members of the CHIPAC meet with candidates and evaluate the candidates’ positions on key issues of concern to the biomedical industry. The CHIPAC may also contribute to those already in office who have demonstrated leadership in advancing biomedical innovation and patient access in California.

How much may I contribute to the CHIPAC? Participation in the CHIPAC is voluntary and there is no minimum donation; the maximum allowed by any individual or company (and its subsidiaries) is $6,500 per calendar year. A suggested contribution level for personal donations, consistent with average contributions to other PACs, is ½ percent to 1 percent of salary. Annual contributors receive a wide array of benefits based on their contribution level including complimentary event attendance, recognition by the CHIPAC and educational materials.

How do I join the CHIPAC? Go to www.chi.org/CHIforms/JoinPAC.aspx and complete the online CHIPAC participation form with a contribution. United we can support candidates who encourage medical innovation, advance product development, and promote the growth of the life sciences industry in California. Contact Consuelo Hernandez (916-233-3497 or [email protected]) or Molly Ingraham (858-456-8884 or [email protected]) to join and contribute.

CONTRIBUTING TO CHIPAC



13

CHI offers opportunities for students, patients and speakers to attend CHI events and meet and network with biomedical leaders and policymakers. Students can be enrolled in a two- or four-year accredited university studying a science or business major in the lifesciences or biomedical industry. Each donation ensures that more individuals can receive support to continue fostering biomedical innovation in California.

Scholarship Benefits• Enhance your visibility as an industry leader who fosters education and career advancement.• Ensure a qualified workforce and develop the lifesciences industry leaders of tomorrow.• Increase the opportunity for more qualified students to receive scholarships through CHI.

Scholarship Options

Platinum Scholarship Funds - $50,000+Contributors establish a named endowment scholarship fund by committing to donate a minimum of $50,000 (in one to four years). The funds generated are used to distribute scholarships starting at $2,000 to qualified applicants.

Gold Scholarship Funds - $25,000+For the opportunity to have a scholarship named and represented by your company or an individual’s name, this is the option for you. The Gold Scholarship Fund is an active expendable fund that allowscontributors to donate $25,000 or more in a given year. The contribution is used to distribute scholarships starting at $2,000 to qualified applicants.

General Scholarship ProgramScholarship donors will be recognized for any size donation. This fund supports highly qualified recipients from our general pool of applicants.

Scholarship Fund Recognition:• Scholarships awarded in the name designated by the donor• The opportunity to invite scholarship recipients to CHI events• Recognition on CHI website• Recognition at CHI events• Invitation to attend CHI events

CHI SCHOLARSHIP OPPORTUNITIES

CHI DIAMOND SPONSORSHIP PROGRAMAs an industry, we face serious challenges in the years ahead due to the consequences of the recent economic turmoil. We need to sustain a strong, consistent voice in the ongoing debate over medical innovation in order to foster a favorable policy and economic environment. The CHI Diamond Sponsorship Program enables your company to donate a lump sum for CHI to use to support our public policy programs and outreach to the California congressional delegation, key congressional committees, federal and state agencies, state legislators and legislative staff. These grants will significantly benefit CHI’s public policy research and advocacy at the federal and state levels in the future, and increase CHI’s impact in both areas. As a donor, you will receive regular reports on how the funding is applied, the progress we are making, and the results we achieve. As an organization, we are inspired by your confidence in CHI to educate policymakers about the key issues facing life sciences innovators.

CHI will work to create a customized package for you. Contact Molly Ingraham, vice-president-business development to learn more ([email protected] or 858-456-8884).



14

SPONSORSHIP LEVELS AT A GLANCE

Winter - Annual California Biomedical Industry Report (Sacramento)

Benefits Additional Benefits

Sponsorship Opportunities

Exclusive reception with policy makers in Sacramento

Recognition on print/ electronicmaterials

Speaking opportunites at project-related

events1

Photo Opportunity

with policymakers

Platinum $10,000

Preferred seating at project-related events; Table for eight guests at press briefing and event to be held in San

Francisco during the Annual J.P. Morgan Healthcare Conference.

Gold $5,000

Two complimentary tickets to press conference and invitation-only

networking breakfast at J.P. Morgan Healthcare Conference

Non-Profit/Academic Research Institution

$3,500

Two complimentary tickets to press conference and invitation-only

networking breakfast at J.P. Morgan Healthcare Conference

Spring - Annual Reception on Capitol Hill (Washington, D.C.)



Complimentary Registrations


Recognition during event

Recognition on CHI website

Platinum $7,500 8 Seat at honoree table; Photo opportunity

with honoree2

Gold $3,000 2

Summer - An Evening With Thought Leaders (Southern California)







Literature display

Platinum $20,000 8

Exclusive sponsorship; Opportunity to speak*;

Table of eight at dinner; Distribution of

giveaway to attendees*; Opportunity to serve

on Event Steering Committee*; Preferred

seating

Gold $10,000 4

Opportunity to serve on Event Steering

Committee*

Silver$5,000 2

* Subject to CHI approval

2 Schedule permitting

1 Subject to CHI, PwC, and BayBio approval



15

SPONSORSHIP LEVELS AT A GLANCE

Fall - CHI Annual Meeting - Bay Area







Literature display

Board Dinner$25,000

6Table of eight at dinner;

Opportunity to speak

Platinum $20,000

6Opportunity to speak;

Distribution of giveaway

Gold $10,000

4

Silver $5,000

2

Coffee and Networking Break $5,000

2

Patient and Non-Profit Organization Scholarship

$5,0002

End of Session Reception (Washington, D.C.)


Sponsorship Opportunity

Recognition on printed/ electronic

materials


$1,500 Targeted campaign to congressional offices

Fall - Annual Diagnostics Forum


Sponsorship Opportunity





Literature display

$3,500 2Opportunity to present;

Opportunity to guide white paper development



16

CHI BOARD OF DIRECTORS

Carl W. Hull (Chairman)

David E. I. Pyott (Chairman-Elect)

David L. Gollaher, Ph.D. (President & CEO)

David W. Beier

Mark Carlson, M.D.

Michael V. Drake, M.D.

Peter C. Farrell, Ph.D.,DSc, AM

Paul Hastings

Peter Barton Hutt

Vera Janushkowsky

Steve E. Krognes

Sef P. Kurstjens, M.D., Ph.D

Tracy T. Lefteroff

John C. Martin, Ph.D.

Daniel McIntyre

Dana G. Mead, Jr.

David Meeker, M.D.

Peter G. Milner, M.D., FACC

Michael A. Mussallem

Maulik Navanaty

Christian W. Nolet

John C. Reed, M.D., Ph.D.

William E. Rhodes

John D. Stobo, M.D.

Katie M. Szyman

Eric J. Topol, M.D.

Keith C. Valentine

David J. Wilson, Ph.D.

Rick E. Winningham

Hologic + Gen-Probe

Allergan

CHI-California Healthcare Institute

Amgen

St. Jude Medical, Inc.

U.C. Irvine

ResMed

OncoMed Pharmaceuticals

Covington & Burling

Pfizer

Genentech

Agensys, Inc.

PricewaterhouseCoopers

Gilead Sciences

Biogen Idec

Kleiner Perkins Caufield & Byers

Genzyme

Optivia Biotechnology

Edwards Lifesciences

Boston Scientific - Neuromodulation

Ernst & Young

Sanford-Burnham Medical Research Institute

BD Biosciences

University of California

Medtronic Diabetes

Scripps Translational Science Institute,

Scripps Health & West Wireless Health Institute

NuVasive, Inc.

Mentor Worldwide

Theravance



17

CHI MEMBERS

23andMeAbbott DiabetesAbbott DiagnosticsAbbott HematologyAbbott LaboratoriesAbbott Medical OpticsAbbott Vascular AccurayAchaogenAdvanced Cleanroom Microclean (ACM)AeroGenAffymax AgensysAlexandria Real Estate EquitiesAlign TechnologyALine, IncAlios BioPharmaAllerganAlphatec SpineALZA CorporationAmgenAmira PharmaceuticalsAmylin PharmaceuticalsAndrew TechnologiesAptiv SolutionsAradigmAragon PharmaceuticalsArena Pharmaceuticals ArmetheonASP – Johnson & JohnsonAstellas Pharma USAvalon VenturesAvid BioticsBabyCenterBaxanoBavarian NordicBDBD BiosciencesBD Diagnostics - GeneOhmBeckman CoulterBeckman Laser InstituteBerkeley HeartLabBiogen IdecBioMarin PharmaceuticalBiosense WebsterBionizBiPar SciencesBN ImmunotherapeuticsBoehringer IngelheimBoston Consulting GroupBoston ScientificBoston Scientific – Cryovascular SystemsBoston Scientific – ElectrophysiologyBoston Scientific EPI Technology CenterBoston Scientific IVT Technology CenterBoston Scientific – NeuromodulationBoston Scientific – Smart TherapeuticsBuck Institute for Age ResearchCabochon AestheticsCaltag LaboratoriesCardioDxCedars-Sinai Health System Celera Diagnostics

Cellegy PharmaceuticalsCentocorCepheidCerexaChapman UniversityCity of HopeCODAN U.S. CorporationConceptusCooley LLPCougar BiotechnologyCovington & Burling LLPCrescendo BioscienceCubist PharmaceuticalsCytokinetics CytRxDePuyDexComDuane MorrisDURECTEdwards LifesciencesElcelyx TherapeuticsElevation PharmaceuticalsErnst & YoungExelixisExploraMedFabiani & CompanyFIBERLite Centrifuge Inc.Forest LaboratoriesFish & Richardson GeniaGenentechGenomic HealthGenomics Institute of the Novartis Research FoundationGenoptixGenzyme CorporationGenzyme DiagnosticsGenzyme GeneticsGilead SciencesGlaxoSmithKlineGround Zero PharmaceuticalsHistogenHoffman-La Roche LtdHogan LovellsHologic + Gen-ProbeIDA IrelandIDM Pharma, Inc.IlluminaImpedimedInterventional SpineIntuitive SurgicaliRhythmIrvine ScientificIsis PharmaceuticalsISTA PharmaceuticalsIverson Genetic DiagnosticsJ&J Pharmaceutical Research & DevelopmentJohnson & JohnsonK-Tube CorporationKleiner Perkins Caufield & Byers LLPKPMG LLPLa Jolla Institute for Allergy and ImmunologyLazard LTDLeerink Swann



18

LifeScanLoneStar HeartMcKessonMedImmuneMedImmune VaccinesMedtronicMedtronic Cardiovascular (Santa Rosa/Santa Ana)Medtronic Spinal & Biologics (Sunnyvale)Medtronic Diabetes (Northridge)Medtronic Surgical Technologies (Goleta)Mentor CorporationMerck & CoMerrill DataSiteMetabolexMicrogenicsMyMedicalRecordsMyoscienceNEKTAR TherapeuticsNeuroPaceNeutrogenaNitinol Devices & ComponentsNodality Novo NordiskNuVasiveOkapi Venture CapitalOligasisOmnioxOncoMed PharmaceuticalsOnyx PharmaceuticalsOphthonixOptiMedicaOptimer PharmaceuticalsOptivia BiotechnologyOrexigen TherapeuticsOrganovoOrtho DermatologicsPfizerPhotoTheraPoniard PharmaceuticalsPortola PharmaceuticalsPricewaterhouseCoopers LLPProteus BiomedicalQuidelRadiant ResearchRegulus TherapeuticsRevance TherapeuticsResMed Rigel PharmaceuticalsRocheRoche Molecular DiagnosticsRox MedicalSafety SyringesSanford-Burnham Medical Research InstituteSangamo BioSciencesSangartSantarusSciosSI-BoneSidley Austin Siemens Healthcare

SientraSinuSysSpectrum PharmaceuticalsSonitus SRI InternationalSt. Jude MedicalStanford Biodesign Innovation ProgramStanford Biodesign NetworkStanford University School of MedicineStrathspey Crown LLCSynteractTakeda PharmaceuticalsTakeda Research InvestmentTakeda San DiegoTakeda San FranciscoTandem DiabetesTarget DiscoveryTelikThallo BiosciencesThe Buck Institute for Age ResearchThe Foundry The J. David Gladstone InstitutesThe Jackson LaboratoryThe Salk Institute for Biological StudiesThe Sam & Rose Stein Institute for Research on AgingThe Scripps Research InstituteTheravanceThermo Fisher ScientificThermo Fisher Scientific – Clinical DiagnosticsThermo Fisher Scientific – Scientific InstrumentsThermo Fisher Scientific – Western Distribution CenterThermo Fisher Scientific – Life Sciences Mass SpectrometryThermo Fisher Scientific – Chino WarehouseThermo Fisher Scientific – Plastic ConsumablesThermo Fisher Scientific – Process Instruments DivisionThermo Fisher Scientific – CentrifugesThermo Fisher Scientific – Laboratory PlasticsThermo Fisher Scientific – Environmental Monitoring TechnologiesTriNetTrius TherapeuticsUC, BerkeleyUC, DavisUC, IrvineUC, Los AngelesUC, RiversideUC, San DiegoUC, Santa BarbaraUC, Santa CruzUniversity of CaliforniaUniversity of Southern CaliforniaVeridexVivusVolcano CorporationWaveTec Vision Wave 80 BiosciencesWilson Sonsini Goodrich & RosatiWind RiverXOMA (US) LLCZimmer DentalZimmer Holdings

CHI MEMBERS



19

SPONSORSHIP COMMITMENT FORM

Company Information

Organization Name Address 1

Website Address 2

Type of Business City, State

Contact Name Zip

Contact Title Phone

E-mail Fax

Billing Information__ Same as above

(Indicate who should receive sponsorship invoice)

Contact Name Address 1

Contact Title Address 2

Phone City

Fax State

E-mail Zip

Payment Method(Please check one) __ Check Enclosed __ Visa/MC/Amex __ Please Invoice

Card Number Exp. Date

Cardholder Name Address 1

Total $ Address 2

Phone City, State

E-mail Zip

Cardholder Signature

Please mail, fax, or e-mail sponsorship committment form to:Attn: CHI Business Development, California Healthcare Institute, 888 Prospect Street, Suite 220, La Jolla, CA 92037

(858) 551-6677 | (858) 551-6688 fax | [email protected]

California Biomedical Industry Report

□ Platinum ($10,000)

□ Gold ($5,000)

□ Non-Profit/Academic Research Institution ($3,500)

Annual Reception in D.C.


□ Gold ($3,000)

An Evening With Thought Leaders


□ Gold ($10,000)

□ Silver ($5,000)

Annual Diagnostics Forum

□ $3,500

End of Session Reception in D.C.

□ $1,500CHI Annual Meeting

□ Board Dinner ($25,000)


□ Gold ($10,000)

□ Silver ($5,000)

□ Coffee/Networking Break ($5,000)

□ Patient/Non-Profit Scholarship ($5,000)

Sponsorship Information

Coverage, Payment & the Value of Biomedical Innovation

□ Presenting Level ($25,000)

□ Supporting Level ($10,000)

NIH Return on Investment

□ Corporate Level ($10,000)

□ Non-Profit/Academic Research Institution Level ($5,000)

Download - SPONSORSHIP OPPORTUNITIES - California Life Sciences ... · SPONSORSHIP OPPORTUNITIES Platinum Sponsor Benefits - $10,000 • Recognition of research milestone, product development

Top Related